Japan Tissue Engineering Co., Ltd. (TYO:7774)

Japan · Delayed Price · Currency is JPY

730.00

-2.00 (-0.27%)

Oct 26, 2026, 3:30 PM JST

Market Cap	29.65B +46.0%
Revenue (ttm)	2.52B +3.4%
Net Income	-440.13M
EPS	-10.84
Shares Out	40.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,600
Open	730.00
Previous Close	732.00
Day's Range	715.00 - 736.00
52-Week Range	448.00 - 927.00
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Japan Tissue Engineering

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Contract, and Lab Site Project segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it offers EPI-MODEL, a reconstructed human epidermis model. Further, the company offers regenerativ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1999

Employees 200

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 7774

Full Company Profile

Financial Performance

In fiscal year 2026, Japan Tissue Engineering's revenue was 2.18 billion, a decrease of -11.12% compared to the previous year's 2.46 billion. Losses were -734.00 million, 187.8% more than in 2025.

Financial Statements